The effect of implementation of a ramp test to optimize LVAD pump speed on clinical and echocardiographic outcomes.

The effect of implementation of a ramp test to optimize LVAD pump speed on clinical and echocardiographic outcomes. - LVAD pump speed optimalisation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41197

Enrollment

Unknown

Registered

2014-05-20

Start date

2014-06-12

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure left ventricular mechanical assistance

Interventions

Study patients will undergo adjustments to the pump speed of the HVAD. The HVAD has an European Commercial approval since January 2009. Normal pump speed recommended by the manufacturer is between 2

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The subject is 18 years or older - The subject must have a HeartWare Ventricular Assist Device (HVAD) implanted as destination therapy in the LUMC. - The subject must be in a hemodynamically stable condition.

Exclusion criteria

Exclusion criteria: A potential subject will be excluded if he or she does not meet the inclusion criteria at the moment of inclusion or during the studied period.

Design outcomes

Primary

Measure	Time frame
The effect of pump speed optimizing on clinical (including NYHA class, pro-BNP, quality of life assessment, 6 minute walking test and bicycle test) and echocardiographic parameters at 3 months follow-up.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)